Status:
ENROLLING_BY_INVITATION
Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Haemophilia A
Eligibility:
All Genders
Brief Summary
This non-interventional study concerns a safety data collection based on adverse event data from a third-party registry (European Haemophilia Safety Surveillance System, EUHASS) that includes informat...
Eligibility Criteria
Inclusion
- Participation in the European Haemophilia Safety Surveillance System (EUHASS).
Exclusion
- N/A
Key Trial Info
Start Date :
December 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04682145
Start Date
December 9 2020
End Date
February 1 2026
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Søborg, Denmark, 2860